Literature DB >> 15354744

Immunoperoxidase staining for C4d on paraffin-embedded tissue in cardiac allograft endomyocardial biopsies: comparison to frozen tissue immunofluorescence.

Chavit Chantranuwat1, Jian-Hua Qiao, Jon Kobashigawa, Longsheng Hong, Peter Shintaku, Michael C Fishbein.   

Abstract

C4d deposition in microvasculature is a marker for humoral rejection. The authors compared a recently developed C4d immunoperoxidase (IP) method for paraffin-embedded tissue to immunofluorescence (IF) of frozen tissue. Of 315 frozen endomyocardial biopsies with IF staining for C4d, 280 were negative and 35 were positive. Negative controls were 17 negative biopsies and 11 biopsies with myocyte necrosis. The extent of IP and IF staining was graded as 0 to 3+. Staining intensity and the number and type of positive vessels were recorded. Staining patterns in Quilty lesions (QL) and foci of acute cellular rejection (ACR) were also evaluated. In 34 biopsies with sufficient tissue, IP criteria of 2+/3+, or more than 10 to 20 positive vessels per 10 high-power fields detected 25.0% (1/4), 18.2% (2/11), and 84.2% (16/19) of 1+, 2+, and 3+ IF-positive biopsies, respectively, without false positives. Considering C4d IF 3+ as positive resulted in 84.2% (16/19) sensitivity and 93.0% specificity (40/43). Intensely stained capillaries predominated in six of seven biopsies when more than 100 capillaries per 10 high-power fields were positive. Seventy percent (7/10) of IP 2+ and 3+ biopsies showed positive capillaries in QLs, while 36.4% (4/11) of IP 1+ and negative biopsies did. All eight IP 2+/3+ biopsies showed positive capillaries in ACR foci, while 25.0% (1/4) of IP-negative biopsies did. Capillary staining in QLs and areas of ACR reflects overall C4d deposition. In conclusion, IP staining of 2+/3+ is highly sensitive and specific for C4d positivity. The authors recommend considering 2+ and 3+ as positive staining when using the IP technique.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15354744     DOI: 10.1097/00129039-200406000-00012

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  6 in total

1.  Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers.

Authors:  E R Rodriguez; Diane V Skojec; Carmela D Tan; Andrea A Zachary; Edward K Kasper; John V Conte; William M Baldwin
Journal:  Am J Transplant       Date:  2005-11       Impact factor: 8.086

2.  Report from a consensus conference on antibody-mediated rejection in heart transplantation.

Authors:  Jon Kobashigawa; Maria G Crespo-Leiro; Stephan M Ensminger; Hermann Reichenspurner; Annalisa Angelini; Gerald Berry; Margaret Burke; Lawrence Czer; Nicola Hiemann; Abdallah G Kfoury; Donna Mancini; Paul Mohacsi; Jignesh Patel; Naveen Pereira; Jeffrey L Platt; Elaine F Reed; Nancy Reinsmoen; E Rene Rodriguez; Marlene L Rose; Stuart D Russell; Randy Starling; Nicole Suciu-Foca; Jose Tallaj; David O Taylor; Adrian Van Bakel; Lori West; Adriana Zeevi; Andreas Zuckermann
Journal:  J Heart Lung Transplant       Date:  2011-03       Impact factor: 10.247

3.  Utility of C4d immunostaining in the first year after pediatric and young adult heart transplantation.

Authors:  Ying Xu; Csaba Galambos; Miguel Reyes-Múgica; Susan A Miller; Adriana Zeevi; Steven A Webber; Brian Feingold
Journal:  J Heart Lung Transplant       Date:  2013-01       Impact factor: 10.247

4.  Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes.

Authors:  Grace W Wu; Jon A Kobashigawa; Michael C Fishbein; Jignesh K Patel; Michelle M Kittleson; Elaine F Reed; Krista K Kiyosaki; Abbas Ardehali
Journal:  J Heart Lung Transplant       Date:  2009-03-14       Impact factor: 10.247

5.  Pathogenesis and significance of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways.

Authors:  Min-Kyung Kim; Young-In Maeng; Sun-Jae Lee; In Hee Lee; Jisuk Bae; Yu-Na Kang; Byung-Tae Park; Kwan-Kyu Park
Journal:  Int J Clin Exp Pathol       Date:  2013-09-15

Review 6.  Immunosuppression for lung transplantation.

Authors:  Choo Y Ng; Joren C Madsen; Bruce R Rosengard; James S Allan
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.